Journal of obstetrics and women's diseases

Peer-review medical journal

Editor-in-Chief

Eduard K. Ailamazyan, MD, PhD, Academician of the Russian Academy of Sciences

The Journal has been issued since 1887. It is the first scientific journal in Russia for obstetricians and gynecologists. For over a century, the Journal regularly covers the latest achievements of Russian science.

Journal of Obstetrics and Women's Diseases, a Gold Open Access journal, publishes six volumes per year. Additionally, the Journal will publish occasional special issues featuring selected papers from major conferences.

Abstracting and Indexing

Journal Topics

Journal of Obstetrics and Women's Diseases is a scientific and practical peer-reviewed medical journal, which discusses the most pressing health issues:

  • reproductive health;
  • results of clinical and sociological research;
  • current problems in perinatal obstetrics;
  • issues of gynecological endocrinology, pregravid preparation, and family planning;
  • actual problems in operative gynecology;
  • diagnostics and therapy of reproductive tract infections;
  • advances in clinical genetics and prenatal diagnosis of hereditary and congenital diseases, immunology, and pathology;
  • new and important information and recommendations for the practical physicians (introduction of modern diagnostic and therapeutic technologies, the use of effective drugs, etc.);
  • impact of harmful environmental and production factors on the female reproductive system.

Journal Mission

The main mission of the Journal is to provide new scientific and technical information, to promote scientific knowledge, to help obstetricians and gynecologists to choose the best methods of diagnosis and treatment, and to help improve their skills.

The publications of the Journal are of interest to a wide range of scholars in the field of obstetrics, gynecology, reproduction, genetics, pathology, and immunology of reproduction, as well as for medicine and biology tutors and students.

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription Access

Vol 75, No 1 (2026)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Original study articles

The mathematical model for assessing the risk of negative quality of life declines in women with uterine fibroids without indications for surgical treatment
Aganezova N.V., Aganezov S.S., Buryak M.M.
Abstract

BACKGROUND: An increasing number of women of early reproductive age have uterine fibroids but are postponing their fertility and are interested in using highly effective contraception, including combined oral contraceptives. Clinical manifestations of uterine fibroids can negatively affect patients’ quality of life. However, a single study has published the results of a positive impact of combined oral contraceptive use on the quality of life in women with uterine fibroids. The specific factors that contribute most significantly to the negative impact on the quality of life in this cohort of women and their relative importance have not been studied.

AIM: The aim of this study was to identify factors that influence the quality of life of women with types 3, 4, 5, and 6 uterine fibroids according to the Federation International of Gynaecology and Obstetrics (FIGO) classification without indications for surgical treatment, and to generate a mathematical model to assess the risk of negative quality of life declines in this cohort of patients.

METHODS: This study included patients with FIGO types 3, 4, 5, and 6 uterine fibroids without indications for surgical treatment. Some used multiphasic (ethinyl estradiol + desogestrel) or monophasic (ethinyl estradiol + various progestogens) combined oral contraceptives. Various clinical, anamnestic, and psychosocial characteristics of the patients were initially recorded. Quality of life was assessed at baseline and after 12 months, using the SF-36 questionnaire, and the size of the fibroid nodes was evaluated by ultrasound examination. We used standard methods for comparative statistical analysis, the classification tree method, and logistic regression tools.

RESULTS: Of the 118 patients, 54 used combined oral contraceptives, while 64 did not. Based on the analysis of 48 different clinical, instrumental, laboratory and anamnestic data, four parameters were found to be significant for the quality of life of such patients: greater age (x1), longer diameter of the largest/single fibroid (mm) (x2), presence of symptoms of uterine fibroids (x3) reduces the quality of life and increases the risk of its negative declines, and use of multiphasic/monophasic combined oral contraceptives (x4) is the only factor that increases the quality of life and reduces the risk of its negative declines. Using logistic regression, a model was created to assess the risk of negative quality of life declines in the studied cohort of patients: ψ=0.099x1+0.111x2+2.369x3−6.577x4−4.879.

CONCLUSION: The data obtained allow concluding that the use of both multiphasic and monophasic low-dose combined oral contraceptives is an equally highly effective technology that helps reduce the risk of negative quality of life declines in patients with FIGO types 3, 4, 5, and 6 uterine fibroids without indications for surgical treatment.

Journal of obstetrics and women's diseases. 2026;75(1):5-16
pages 5-16 views
Prediction of pelvic floor dysfunction in women
Bezmenko A.A., Zakharov I.S., Bezhenar V.F., Staroverova A.S., Bagramyan E.A.
Abstract

BACKGROUND: Pelvic floor pathology is a leading cause of gynecological disease, affecting many women of all ages and negatively impacting their quality of life. Despite numerous scientific publications and constantly evolving approaches to diagnosis and treatment, many questions remain open, and the need to improve early diagnosis and prevention methods continues to be an urgent task. The need to implement innovative analytical tools based on mathematical predictive models underscores the critical importance of in-depth study of the risk factors that influence the development of pelvic floor dysfunction.

AIM: Based on the analysis of the anatomical and functional characteristics of the female pelvic floor, the aim of this study was to develop a prognostic model for assessing the risk of developing pelvic dysfunctions in women.

METHODS: A single-center case-control study was conducted. In Group 1, patients reported the onset of pelvic floor dysfunction symptoms within the past 12 months; in Group 2, there were no complaints associated with pelvic dysfunction. Inclusion criteria were age above 18 years or older, Caucasian ethnicity, and signed informed consent. Pregnant women, recent postpartum women (less than 24 months), and those with acute gynecological conditions or genital malformations were excluded. Anatomical and functional characteristics were evaluated using the Pelvic Organ Prolapse Quantification System (POP-Q) and PERFECT systems, alongside pelvic floor ultrasound measurements. Binary logistic regression was utilized to develop a predictive model, validated by ROC curve analysis.

RESULTS: The study involved 218 women: 115 patients in Group 1 and 103 patients in Group 2. The most significant predictors for pelvic floor dysfunction included pelvic floor muscle contraction strength (p = 0.012), difference in urethral inclination α-angle at rest and during the Valsalva maneuver (p = 0.016), height of the perineal tendon center (p = 0.017), number of pelvic muscle contraction repetitions when assessed using the PERFECT system (p = 0.019), thickness of musculus puborectalis (p = 0.030), thickness of musculus bulbospongiosus (p = 0.030), pelvic floor muscle endurance (p = 0.039), and asymmetry index of musculi bulbospongiosus (p = 0.046). The model demonstrated high predictive accuracy (AUC 0.870; sensitivity 78.3%, specificity 82.5%).

CONCLUSION: The created model for assessing the risk of developing pelvic floor dysfunction has high prognostic characteristics. A key advantage of the created model is its universality in relation to the age of patients, which allows assessing the risk of pelvic dysfunction in women at different age periods. Using the created model for assessing the probability of developing pelvic dysfunction in women will enable timely correction of any identified pathology.

Journal of obstetrics and women's diseases. 2026;75(1):17-24
pages 17-24 views
Cytokine production in women with different stages of endometriosis
Grigoryants A.A., Krukier I.I., Avrutskaya V.V., Levkovich M.А., Sarkisyan O.G., Reshetnikova E.A.
Abstract

BACKGROUND: Endometriosis is the third most common gynecological disease. The disruption of the cellular and cytokine-mediated mechanisms underlying the course of this pathology remains poorly understood.

AIM: The aim of this study was to evaluate blood serum and peritoneal fluid cytokine levels at various stages of endometriosis in women of reproductive age.

METHODS: This case-control study included patients aged 17–25 years who were diagnosed with endometriosis stages I–II (Group I) and stages III–IV (Group II). The comparison group included apparently healthy women. Blood serum and peritoneal fluid levels of tumor necrosis factor-alpha, transforming growth factor-beta, and interleukins IL-13 and IL-23 were determined by enzyme-linked immunosorbent assay using reagents manufactured in the USA.

RESULTS: The study included 77 women. Group I consisted of 22 patients, and Group II of 25 patients. The comparison group comprised 30 apparently healthy women. The most significant changes in the blood serum of patients in Group I were observed in IL-23 level, which was increased by 2.65 times compared to the comparison group. In patients in Group II with endometriosis stages III–IV, the most significant changes in the peritoneal fluid were observed in tumor necrosis factor-alpha level, which was increased by 3.2 times compared to the comparison group. In contrast, IL-13 level dropped sharply in both peritoneal fluid and blood serum (on average, by 63% compared to the comparison group).

CONCLUSION: The identified general patterns and characteristics of regulatory responses in endometriosis expand our understanding of the mechanisms of disease development and treatment prospects.

Journal of obstetrics and women's diseases. 2026;75(1):25-31
pages 25-31 views
Pathogenetic interrelationship between genetic factors and oxidative stress in the development of early preeclampsia in multiple pregnancy
Kudrinskikh I.A., Belotserkovtseva L.D., Mordovina I.I., Glotov A.S.
Abstract

BACKGROUND: Early-onset preeclampsia in multifetal pregnancy is a major clinical challenge associated with high maternal and perinatal morbidity and mortality. Its pathogenesis is complex and is thought to arise from interactions between genetic susceptibility and environmental factors, with oxidative stress representing a key mechanistic component. Although the genetic basis of oxidative stress has been investigated in a number of domestic and international research centers, comprehensive studies that integrate the epistatic interactions between genes and their relationship to oxidative status in patients with multifetal pregnancy remain scarce.

AIM: The aim of this study was to assess the frequency of polymorphic variants in genes involved in hemostasis and folate metabolism, identify significant epistatic interactions, and evaluate oxidative status markers in patients with multifetal pregnancy complicated by early-onset preeclampsia.

METHODS: This single-center case-control study included patients with multifetal pregnancy, with or without preeclampsia. Genotyping of 12 single nucleotide variants in hemostasis related genes (F2, F5, F7, F13, FGB, ITGA2, ITGB3, SERPINE1) and folate cycle genes (MTHFR, MTRR, MTR) was performed using real-time polymerase chain reaction. Oxidative status was assessed by total antioxidant capacity, lipid peroxidation index (PerOx), and the integral oxidative stress index (OxyStat). Epistasis was explored using the generalized multifactor dimensionality reduction (GMDR) method.

RESULTS: The study included 157 women (main group: 38 women with early-onset preeclampsia; control group: 119 women without preeclampsia). The carriage of minor alleles in the SERPINE1 −6755G>4G, ITGA2 807C>T, and MTRR 66A>G gene variants was associated with an increased risk of early-onset preeclampsia in multifetal pregnancy. The GMDR method identified significant epistatic interactions; the most predictive three-locus model (ITGA2 + SERPINE1 + MTRR genes) achieved a balanced accuracy of 0.8902 with a sensitivity of 97.5%. Patients with preeclampsia exhibited a marked oxidative imbalance, with a 4.2-fold decrease in total antioxidant capacity and nearly 3-fold increases in PerOx and OxyStat compared to control values. The carriage of the SERPINE1 4G allele and the ITGA2 T allele was associated with more pronounced impairment of oxidative status.

CONCLUSION: The data obtained support a plausible pathogenic link between genetic susceptibility and oxidative stress in early-onset preeclampsia in multifetal pregnancy. Unfavorable genotype combinations in the SERPINE1, ITGA2, and MTRR genes may confer a high genetic risk that, in the context of multifetal gestation, is realized through hypercoagulability, endothelial dysfunction, and placental ischemia-reperfusion, culminating in severe oxidative stress and clinical manifestation of preeclampsia. The results substantiate the rationale for a comprehensive risk stratification approach integrating genetic testing and oxidative status assessment.

Journal of obstetrics and women's diseases. 2026;75(1):32-43
pages 32-43 views
Evaluation of oxidative stress parameters and activation of intracellular signaling pathways in the placenta in experimental methionine-induced hyperhomocysteinemia
Milyutina Y.P., Zalozniaia I.V., Mikhel A.V., Gorbova A.V., Korenevsky A.V., Tolibova G.K., Arutjunyan A.V., Bespalova O.N.
Abstract

BACKGROUND: Maternal hyperhomocysteinemia is commonly regarded as a marker of folate deficiency. However, there is ample evidence to designate this condition as an additional risk factor for obstetric complications, which requires a separate approach to conducting clinical and preclinical studies, and accordingly, to selecting an experimental model for in vivo research. The mechanisms underlying the negative impact of homocysteine and its metabolites on the placenta remain poorly understood. Of interest is the investigation of signaling pathways linking hyperhomocysteinemia to the development of oxidative stress and altered angiogenesis, which leads to insufficient blood flow and placental dysfunction.

AIM: The aim of this study was to evaluate oxidative stress and activation of intracellular signaling pathways in the placenta in experimental methionine-induced hyperhomocysteinemia.

METHODS: A randomized clinical trial was conducted. Hyperhomocysteinemia in female Wistar rats was induced by daily oral administration of methionine (0.6 g/kg body weight) from day 4 of pregnancy until the material was collected. On days 14 and 20 of pregnancy, the placenta was assessed for oxidative stress parameters, the levels of nuclear factor erythroid 2-related factor 2 (NRF2), tumor protein p53, signal transducer and activator of transcription 3 (STAT3), the activation of p38 mitogen-activated protein kinase (p38 MAPK), and apoptosis-inducing factor (AIF) expression levels.

RESULTS: In methionine-induced hyperhomocysteinemia in pregnant rats, the placenta showed an increase in malondialdehyde levels on days 14 and 20 of pregnancy, without changes in catalase activity and antiradical activity. On day 14 of pregnancy, hyperhomocysteinemia in the rat placenta revealed no changes in NRF2, STAT3 and p53 leveles, or the phospho-p38/p38 MAPK ratio. However, on day 20, a decrease in NRF2 levels and an increase in p53 and AIF levels, and the phospho-p38/p38 MAPK ratio were observed.

CONCLUSION: The data obtained suggest that increased oxidative stress associated with hyperhomocysteinemia activates signaling pathways in the placenta, including those related to cell death regulation. This may cause disruptions in angiogenesis, leading to adverse pregnancy outcomes.

Journal of obstetrics and women's diseases. 2026;75(1):44-55
pages 44-55 views
Inflammatory changes of the placenta in fetal death before 28 weeks of gestation: a case-control study
Mukovnikova E.V., Orazmuradov A.A., Kostin I.N., Khamoshina M.B., Doronina O.K., Orazmuradova G.A.
Abstract

BACKGROUND: Late intrauterine fetal death is the dominant cause of perinatal mortality in developed economies. Despite progress in reducing neonatal mortality, the incidence of stillbirths has stagnated over the past decades. Morphological examination of the placenta, which provides a wealth of diagnostic information, has the potential of in-depth insight into the pathophysiological mechanisms that underlie adverse pregnancy outcomes, including late intrauterine fetal death.

AIM: The aim of this study was to assess the relationship between different types of placental inflammation and fetal death before 28 weeks of gestation.

METHODS: This case-control study included patients with intrauterine fetal death at 22+0–27+6 weeks of gestation (main group) and with a live birth (control group). Morphological examination of the placentas was performed using the standard technique of formalin fixation, alcohol dehydration, and paraffin embedding. Sections approximately 6–8 µm thick were prepared for hematoxylin and eosin staining. For morphological examination, 12 placental samples were prepared (material was collected from the central, paracentral, and peripheral zones, with 4 samples from each zone). Inflammatory changes were determined, expressed as characteristic cellular infiltration of various placental structures, namely, the chorionic plate, basal and parietal decidua, amnion, and villous stroma.

RESULTS: The study included 97 patients, of which 36 women formed the main group and 61 women formed the control group. Inflammation of any localization was 2.4 times more common in the group with late intrauterine fetal death compared to the control group (p = 0.004). Chorioamnionitis, intervillitis, and villitis were 3.7 (p = 0.001), 2.75 (p = 0.003), and 4.5 times (p = 0.02) more common in the stillbirth group, respectively. In the group of women who delivered a live infant, placental inflammation was more often associated with the presence of pathogens than in the group with late intrauterine fetal death (p = 0.003). In patients with stillbirth, the presence of microorganisms in bacterial cultures from the cervical canal was associated with three or more microorganisms in quantities greater than 105 CFU/ml. The leading microorganisms were Staphylococcus aureus, Escherichia coli, Acinetobacter Baumannii, Enterococcus faecalis, Staphylococcus haemolyticus, and Proteus vulgaris. Inflammatory reactions, with the exception of funisitis, were observed more frequently in the placentas of women in the main group.

CONCLUSION: The increased frequency of inflammatory placental lesions in stillbirths suggests that inflammation may play a key role in the etiology of intrauterine fetal death before 28 weeks of gestation.

Journal of obstetrics and women's diseases. 2026;75(1):56-63
pages 56-63 views
Risk factors for human papillomavirus infection in women with different HIV status
Samarina A.V., Shamaeva N.S., Martirosyan M.M.
Abstract

BACKGROUND: Cervical cancer is a leading cause of death in women worldwide. The primary driver of its development is the human papillomavirus (HPV). In women infected with HIV, the prevalence of HPV and, consequently, the incidence of HPV-associated lesions of the cervix and vagina, is higher than in the general population. To prevent these diseases, it is important to understand the factors that increase the risk of HPV infection.

AIM: The aim of this study was to assess the risk factors for HPV infection in women with different HIV status living in St. Petersburg, Russia.

METHODS: This case-control included 100 HIV-infected women (main group) and 100 HIV-negative women (control group) living in St. Petersburg, Russia. Polymerase chain reaction was used to determine the DNA of 21 HPV types, plasma HIV RNA, and CD4+ lymphocyte counts in vaginal and cervical secretions. The clinical and epidemiological characteristics were examined.

RESULTS: The frequency of HPV detection in the vagina and cervical canal was 55% in HIV-infected women and 32% in HIV-negative women. In patients with HIV, the presence of HPV was associated with such clinical characteristics as the duration of HIV infection, the duration of antiretroviral therapy, HIV RNA levels, and CD4+ lymphocyte count. HPV was most frequently detected in the first year after HIV diagnosis, and then the probability of HPV detection decreased almost tenfold as the duration of the disease increased. With a one-year increase in the duration of antiretroviral therapy, the probability of HPV detection in the cervical canal decreased by 1.14 times, and when HIV RNA levels in the blood were >40 copies/ml, HPV prevalence increased by 4.71 times. In the control group, the main risk factors for HPV infection were smoking, the onset of sexual activity before the age of 18, and a large lifetime number of sexual partners.

CONCLUSION: In HIV-positive women, HPV prevalence is influenced by the following clinical characteristics: detectable HIV viral load and immunodeficiency increase the risk of HPV detection, while the use of antiretroviral therapy reduces the risk of HPV infection.

Journal of obstetrics and women's diseases. 2026;75(1):64-72
pages 64-72 views
Oxidative and carbonyl stress parameters and their informative value in women who used alcohol during the I trimester of pregnancy
Semеnova N.V., Novikova E.A., Nikitina O.A., Karacheva A.N., Marianian A.Y., Kolesnikov S.I., Bairova T.A., Belskikh A.V., Belyaeva E.V., Kolesnikova L.I.
Abstract

BACKGROUND: Alcohol consumption during pregnancy has a negative impact on the expectant mother’s body and the fetus, especially in early gestation. Even in small doses, ethanol promotes lipid peroxidation, which is a major pathogenic mechanism for the onset of carbonyl and oxidative stresses. To date, the parameters of these metabolic stresses and their impact in the first trimester of pregnancy remain poorly understood.

AIM: The aim of this study was to evaluate the individual parameters of oxidative and carbonyl stresses in the blood plasma of women in the first trimester of pregnancy and their correlation with phosphatidylethanol level as a marker of alcohol consumption.

METHODS: This case-control study included women in the first trimester of pregnancy. To identify the fact and amount of alcohol consumption, plasma levels of phosphatidylethanol 16:0/18:1 were determined by high-performance liquid chromatography–mass spectrometry. Depending on the marker concentration, groups of women were identified: Group 1, ≤8 ng/ml (non-drinkers, control); Group 2, 8–45 ng/ml (women who consumed less than 1 dose over the past 28 days); and Group 3, ≥45 ng/ml (women who consumed more than 1 dose over the past 28 days). To assess oxidative and carbonyl stress parameters, plasma levels of lipid peroxidation products, advanced oxidation protein products, and oxidative DNA modifications were determined by spectrophotometric and immunoassay methods.

RESULTS: The study included 167 women (n = 63 in Group 1, n = 68 in Group 2, and n = 36 in Group 3). The levels of ketodienes and conjugated trienes in Groups 2 and 3 of women were higher than in the control group (p = 0.001 and p = 0.003, respectively). In Group 2, the levels of advanced oxidation protein products and oxidative DNA modifications were lower than in the control group (p <  0.001 and p <  0.001, respectively) and Group 3 (p = 0.014 and p <  0.001, respectively). ROC analysis showed the diagnostic significance of ketodienes and conjugated trienes (p <  0.001), advanced oxidation protein products (p = 0.057), and 8-OH-deoxyguanosine (p <  0.001) for Group 2 of pregnant women, and only ketodienes and conjugated trienes for Group 3 (p = 0,002). When analyzing pregnant women who consumed alcohol, informative were the levels of advanced oxidation protein products (p = 0,009) and 8-OH-deoxyguanosine (p <  0,001).

CONCLUSION: The consumption of alcohol by pregnant women, even in small doses, affects free radical homeostasis, which can contribute to metabolic disorders in the mother-placenta-fetus system. The use of ROC analysis revealed that oxidative and carbonyl stress parameters are sensitive markers of alcohol consumption in the first trimester of pregnancy.

Journal of obstetrics and women's diseases. 2026;75(1):73-82
pages 73-82 views

Reviews

Tumors and tumor-like masses of anogenital mammary-like glands are rare diseases of the vulva: a literature review
Kulagina N.V., Sudakov D.S., Dymarskaya Y.R., Nikolaeva S.A.
Abstract

This literature review surveys scholarly articles relevant to rare vulvar diseases associated with the presence of ectopic breast tissue in the anogenital region. Because it is morphologically similar to mammary tissue, with its structure occupying an intermediate position between eccrine and apocrine glands, they are termed anogenital mammary-like glands. Most of the literature describing pathological changes in these glands are case reports or small case series. We analyzed 121 clinical cases of medical consultations regarding tumors and tumor-like masses developing from anogenital mammary-like glands. In 8.3% of cases, the tumor consisted of unchanged tissue of the anogenital mammary-like glands. Lactation-related changes in anogenital mammary-like glands during pregnancy or after childbirth were the reason for seeking medical attention in 19.2% of cases. Benign diseases of the anogenital mammary-like glands were detected in 36.7% of cases. These included fibroadenoma, benign phyllodes tumor, papillary hidradenoma, adenoma, fibrocystic breast changes, papillary apocrine fibroadenoma, and benign ductal hyperplasia with adenosis. Malignant tumors of the anogenital mammary-like glands accounted for 35.8% of cases. Histological examination revealed carcinoma, adenocarcinoma, and Paget’s disease. Treatment options depended on the type of malignancy, its receptor status, tumor size and extent of the pathological process, as well as the patient’s age, general health, preferences, and the presence of comorbidities.

Journal of obstetrics and women's diseases. 2026;75(1):83-98
pages 83-98 views
The role of the reproductive tract microbiome in gynecological pathology: modern methods for diagnostics and correction of disorders
Naydenova S.M., Dzukaeva F.I., Kuzmina E.A., Fedorova P.S., Tatarova A.A., Sernovets E.A., Kacher D.A., Karimova G.V., Nayko A.V., Novoselova A.S., Dimitriadi M.V., Valkova A.D., Gergieva A.K., Tsarukaeva A.R.
Abstract

The female reproductive tract microbiota plays a key role in maintaining women’s health, including the reproductive function. Contemporary research refutes the notion of sterility in the upper reproductive tract and proves the existence of unique microbial communities in the vagina, cervical canal, endometrium, fallopian tubes, and ovaries. An imbalance in this ecosystem — dysbiosis — is characterized by a decrease in lactobacilli (especially Lactobacillus crispatus) and an increase in opportunistic pathogens (Gardnerella, Prevotella, Atopobium). This condition is associated with a wide range of pathologies, such as chronic endometritis, infertility, pregnancy loss, pelvic inflammatory disease, and endometriosis, as well as the persistence of human papillomavirus and the progression of cervical neoplasia. Dysbiosis triggers a local inflammatory response, creating unfavorable conditions for embryo implantation and pregnancy progression. The diagnosis of microbiota disorders is currently undergoing significant changes. Traditional methods (microscopy, culture) are increasingly being replaced by high-precision molecular genetic technologies, such as 16S ribosomal RNA gene sequencing and metagenomic analysis, which allow for a detailed characterization of the taxonomic and functional potential of the microbiota. Modern approaches to correcting dysbiosis include not only etiotropic antibiotic therapy but also strategies for restoring a normal microbial balance using probiotics, synbiotics, phage therapy, postbiotics, and promising methods such as vaginal microbiota transplantation. Thus, comprehensive assessment and targeted modulation of the female reproductive tract microbiota open new avenues for personalized and targeted therapy of gynecological diseases and improving reproductive outcomes.

Journal of obstetrics and women's diseases. 2026;75(1):99-114
pages 99-114 views

Case reports

Late diagnosis of müllerian duct anomalies in women: reproductive losses and surgical errors, experience in managing patients with Herlyn–Werner–Wunderlich syndrome
Alexeev G.E., Azizova A.A., Koroleva A.V., Marinenko S.V., Melkonyatc T.G.
Abstract

One in ten women worldwide (285–400 million people) lives with a genitourinary malformation. Urogenital anomalies often remain undetected, despite the advanced 21st century medical technologies. As a result, many of these women undergo infertility treatment without being aware of the true underlying cause of their condition. Using two clinical cases from the authors’ own experience in the management of reproductive-age patients with Müllerian duct anomalies, this article provides a detailed analysis of why timely detection of genitourinary malformations is critically important. In the first clinical case, the patient had an untimely diagnosis of Herlyn–Werner–Wunderlich syndrome, which likely resulted in a series of unnecessary surgical interventions and subsequent complications. In the second clinical case, the patient was diagnosed with a bicornuate uterus, incomplete vaginal duplication, and partial aplasia of the left vagina, which may have been the cause of many years of infertility. In both cases, the patients underwent surgical treatment aimed at creating an artificial perforation of the previously obstructed vagina, thereby enabling free menstrual drainage. Surgical management reduced the risk of complications associated with the development of hematocolpos, hematometra, and hematocervix, and significantly improved the patients’ quality of life. Expert and timely diagnosis, rational surgical management, and a high level of professional expertise enabled these patients to achieve their reproductive goals.

Journal of obstetrics and women's diseases. 2026;75(1):115-125
pages 115-125 views
Case report of live fetal delivery with partial hydatidiform mole
Dikareva L.V., Shvarev E.G., Zoeva A.R., Gadzhieva P.K.
Abstract

Despite their rarity, trophoblastic tumors are an important obstetric problem due to the high risk of severe complications in both the mother and fetus. Trophoblastic disease, including its benign and malignant manifestations, most often affects young women at an age when their social life is most active and their reproductive function is at its peak. This circumstance underscores the importance and urgency of finding effective treatments for this pathology, as well as preserving the reproductive health of patients. Hydatidiform mole is a benign variant of trophoblastic disease. In addition, it poses a serious threat in early pregnancy, as it can be asymptomatic in the first two months of gestation, which in turn creates significant difficulties for its timely diagnosis. The article describes a rare clinical case of pregnancy and delivery of a healthy live fetus with a partial hydatidiform mole, as well as the features of pregnancy and postpartum management. The patient’s pregnancy was accompanied by ovarian hyperstimulation, threatened miscarriage, and premature labor, with bilateral giant theca lutein cysts being formed. The cysts form in the ovaries due to high levels of human chorionic gonadotropin and prolactin. The pregnancy outcome was favorable.

Journal of obstetrics and women's diseases. 2026;75(1):126-132
pages 126-132 views